TP53 and head and neck squamous cell carcinoma: The use of next generation sequencing (NGS) in HNSCC has led to identification of novel mutated tumor suppressor genes (TP53, CDKN2A) and oncogenes (PIK3CA, HRAS, EGFR) and has led to the development of predictive biomarkers.